what are side effects of bpc 157 Multifunctionality and Possible Medical Application the Peptide—Literature and Patent Review BPC-157 for Recovery Support –

Main methods Assessment included magnesium sulfate (560 mg/kg intraperitoneally)-induced muscle weakness, muscle and brain lesions, hypermagnesemia, hyperkalaemia, increased serum enzyme values assessed in rats during and at the end of a 30-min period and medication (given intraperitoneally/kg at 15 min before magnesium) [BPC 157 (10 g, 10 ng), l-NAME (5 mg), l-arginine (100 mg), alone and/or together]

Technical supports: CNW, YSK, VHSC, and JSW

Its popularity is rising, particularly on the internet and in wellness clinics

Bioavailability following subcutaneous injection is estimated at approximately 80%, substantially higher than oral administration, where peptide degradation in the gastrointestinal tract limits systemic exposure